Speciality European Pharma Company Profile

02:39 EST 23rd November 2017 | BioPortfolio

News Articles [1125 Associated News Articles listed on BioPortfolio]

EUSA Pharma: Strategies of a Speciality Company

In this exclusive interview, Fintan Walton talks to Bryan Morton, Founder and CEO of EUSA Pharma. Bryan begins by discussing the establishment of EUSA Pharma, and how its formation was motivated by th...

Archimedes Pharma: A Thriving Speciality Pharma

In this new interview, Fintan Walton talks to Richard de Souza, CEO of Archimedes Pharma. Richard describes how Archimedes' strategy has evolved over the 18 months since his last appearance on PharmaT...

Vifor’s hyperkalaemia drug Veltassa approved in Europe

Vifor Pharma has gained final European marketing approval for its hyperkalaemia treatment Veltassa. The approval is a major milestone for the Switzerland-headquartered speciality pharma company, whic...

NuPathe IPO, PTV News: May 18, 2010

Speciality pharma firm hopes to raise US $86.3M

Sobi appoints Norbert Oppitz SVP, speciality care

He joins the rare disease pharma firm from BSN Medical

Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks

European CAR-T stocks have jumped following Gilead’s announcement that it will acquire Kite Pharma, Novartis’ main competitor to launch the first therapy. Yesterday, Gilead bought a $11.9Bn (€9...

Bayer Schering Pharma: Michael Yeomans on Growth in Pharma and New Deals

In this episode of PharmaTelevision News Review, Fintan Walton talks with Michael Yeomans, VP Business Development & Licensing at Bayer Schering Pharma*. Filmed at BioChicago 2010 in Chicago, USA, the...

Biotech turns Pharma: Medivir's continuing evolution.

Medivir’s Business Development Director, Morten Faester talks to Fintan Walton at AngloNordic Life Science Conference, 2014 in London. Astra’s antiviral spinout has licensed a cold sore product ...

Drugs and Medications [268 Associated Drugs and Medications listed on BioPortfolio]

Mentadent [Church & Dwight Co., Inc.]

Drug Facts

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

PubMed Articles [1912 Associated PubMed Articles listed on BioPortfolio]

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

Clinical Trials Series - Large Pharma.

AI-powered drug discovery captures pharma interest.

A new cross-speciality educational collaboration in perioperative medicine.

Clinical Trials [597 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

A Comparison of European and Chinese Blood Sugar Responses

This study is designed to compare the responses to an oral glucose challenge between people of European and Chinese heritage (essential participants in the European arm must have tow Europ...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Companies [1337 Associated Companies listed on BioPortfolio]

Speciality European Pharma

Masters Speciality Pharma

Chandra Bhagat Pharma Pvt. Ltd.

Chandra bhagat pharma pvt Ltd. a well established pharmaceutical company founded by MR chandravadan C. bhagat an entrepreneur with an imposing record of more than 6 decades devoted to offering a speci...

SLA Pharma AG

S.L.A. Pharma AG is a privately owned Swiss company pioneering the development of speciality pharmaceutical products for gastrointestinal and rare disorders. Their pipeline consis...

Speciality Fibres and Materials Ltd

Speciality Fibres and Materials Limited was acquired from Acordis by Lohmann and Rauscher in February 2005. The business has been committed to the development and manufacture of fibres and their appli...

More Information about "Speciality European Pharma" on BioPortfolio

We have published hundreds of Speciality European Pharma news stories on BioPortfolio along with dozens of Speciality European Pharma Clinical Trials and PubMed Articles about Speciality European Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Speciality European Pharma Companies in our database. You can also find out about relevant Speciality European Pharma Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record